Question 1

What is alkaline ceramidase 3 deficiency?

Accepted Answer

Alkaline ceramidase 3 deficiency is a multisystem condition that primarily affects neurological development and leads to progressive leukodystrophy. It is caused by pathogenic variants in the ACER3 gene, which plays a role in sphingolipid metabolism. The condition is inherited in an autosomal recessive pattern and is very rare, affecting fewer than one in a million people. Onset is in early childhood, and affected individuals experience significant developmental challenges and multiple neurological and systemic features.

Question 2

What are the symptoms of alkaline ceramidase 3 deficiency?

Accepted Answer

The clinical presentation of alkaline ceramidase 3 deficiency includes a distinct constellation of features that affect multiple systems. Affected children exhibit a sloping forehead, coarse facial features, relative macrocephaly, and low-set ears. Neurologically, there is severe intellectual disability, dystonia, and a striking leukodystrophy, along with features such as cerebral atrophy, hypoplasia of the corpus callosum, and optic disc pallor. , after a period of apparently typical early development, affected children experience a phase of developmental regression marked by loss of previously acquired skills. Additional features such as joint contractures, axial hypotonia, appendicular spasticity, and neurogenic bladder are consistently observed. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes alkaline ceramidase 3 deficiency?

Accepted Answer

Alkaline ceramidase 3 deficiency results from mutations in the ACER3 gene. The protein produced by this gene is involved in the metabolism of sphingolipids, which are critical components of cell membranes and important for normal neurological function. This condition is inherited in an autosomal recessive pattern, meaning that an affected individual has received one mutated copy of the gene from each parent. It is more common when parents share a common ancestor because both are more likely to carry the same rare variant, and carrier testing may be particularly relevant for families with shared ancestry. Associated genes include ACER3.

Question 4

How is alkaline ceramidase 3 deficiency inherited?

Accepted Answer

alkaline ceramidase 3 deficiency follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is alkaline ceramidase 3 deficiency?

Accepted Answer

alkaline ceramidase 3 deficiency is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is alkaline ceramidase 3 deficiency diagnosed?

Accepted Answer

Diagnosis of alkaline ceramidase 3 deficiency is confirmed through molecular genetic testing that identifies pathogenic variants in ACER3. Clinical evaluation, including a detailed review of developmental history and characteristic physical features, supports the genetic findings. Because many of these features can overlap with other conditions, definitive diagnosis relies on genetic testing.

Question 7

Are there treatments for alkaline ceramidase 3 deficiency?

Accepted Answer

Currently, management of alkaline ceramidase 3 deficiency focuses on supportive care and symptom management, as there are no FDA-approved treatments. Treatment is tailored to the individual and typically involves a multidisciplinary team to address the range of neurological, developmental, and systemic issues. Regular surveillance is an essential part of long-term care, helping to identify potential complications before they become serious. Patients should discuss treatment options and supportive strategies, including physical and occupational therapies, with their healthcare team, and genetic counseling is recommended to support family planning.

Question 8

What complications can arise from alkaline ceramidase 3 deficiency?

Accepted Answer

Alkaline ceramidase 3 deficiency can lead to various complications due to its impact on neurological development. Affected individuals may experience severe intellectual disability, dystonia, and motor decline over time. Additionally, they may develop joint contractures and issues related to bladder control, which can affect daily activities and overall quality of life.

Question 9

How does alkaline ceramidase 3 deficiency affect daily life for affected children?

Accepted Answer

Children with alkaline ceramidase 3 deficiency often face significant challenges in daily life due to their developmental and neurological issues. They may require assistance with basic activities and benefit from therapies to help with mobility and communication. Supportive care is essential to help them manage symptoms and improve their quality of life.

Question 10

What is the long-term prognosis for someone with alkaline ceramidase 3 deficiency?

Accepted Answer

The prognosis for individuals with alkaline ceramidase 3 deficiency varies widely based on the severity of symptoms and the age at which they are diagnosed. Many experience an initial regression followed by a period of stabilization, but some may face later motor decline. With proper care and support, many individuals can benefit from multidisciplinary management, which can improve their outcomes.

Question 11

What specialists should families consult for managing alkaline ceramidase 3 deficiency?

Accepted Answer

Families managing alkaline ceramidase 3 deficiency should consult a multidisciplinary team of specialists. This may include neurologists, genetic counselors, physical and occupational therapists, and developmental pediatricians. These professionals can help address the range of neurological, developmental, and systemic issues associated with the condition and provide tailored support for the affected individual.

Organ System	Phenotype Count	Example Features
Brain and nerves	6	Dystonia, Severe intellectual disability, Brain shrinkage (cerebral atrophy)

Kisho

alkaline ceramidase 3 deficiency

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

alkaline ceramidase 3 deficiency

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is alkaline ceramidase 3 deficiency?

What are the symptoms of alkaline ceramidase 3 deficiency?

What causes alkaline ceramidase 3 deficiency?

How is alkaline ceramidase 3 deficiency inherited?

How rare is alkaline ceramidase 3 deficiency?

How is alkaline ceramidase 3 deficiency diagnosed?

Are there treatments for alkaline ceramidase 3 deficiency?

What complications can arise from alkaline ceramidase 3 deficiency?

How does alkaline ceramidase 3 deficiency affect daily life for affected children?

What is the long-term prognosis for someone with alkaline ceramidase 3 deficiency?

What specialists should families consult for managing alkaline ceramidase 3 deficiency?

Explore clinical features